Processing

Please wait...

Settings

Settings

1. WO2007064601 - ANTIVIRAL MORINDA CITRIFOLIA L. BASED FORMULATIONS AND METHODS OF ADMINISTRATION

Publication Number WO/2007/064601
Publication Date 07.06.2007
International Application No. PCT/US2006/045439
International Filing Date 27.11.2006
Chapter 2 Demand Filed 27.09.2007
IPC
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36
Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
A61K 36/00 (2006.01)
CPC
A23L 33/105
A23V 2002/00
A61K 2800/782
A61K 36/746
A61K 8/97
A61Q 19/00
Applicants
  • TAHITIAN NONI INTERNATIONAL, INC. [US/US]; 333 WEST RIVER PARK DRIVE Provo, UT 84604, US (AllExceptUS)
  • PALU, Afa, Kehaati [TO/US]; US (UsOnly)
  • ZHOU, Bing-Nan [CN/CN]; US (UsOnly)
  • WEST, Brett, Justin [US/US]; US (UsOnly)
  • JENSEN, Claude, Jarakae [US/US]; US (UsOnly)
  • SU, Chen [US/US]; US (UsOnly)
Inventors
  • PALU, Afa, Kehaati; US
  • ZHOU, Bing-Nan; US
  • WEST, Brett, Justin; US
  • JENSEN, Claude, Jarakae; US
  • SU, Chen; US
Agents
  • MARROT, Jarod, R. ; KIRTON & MCCONKIE 1800 EAGLE GATE TOWER 60 EAST SOUTH TEMPLE Salt Lake City, UT 84111, US
Priority Data
11/562,22421.11.2006US
60/740,59329.11.2005US
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) ANTIVIRAL MORINDA CITRIFOLIA L. BASED FORMULATIONS AND METHODS OF ADMINISTRATION
(FR) FORMULATIONS ANTIVIRALES A BASE DE MORINDA CITRIFOLIA L. ET METHODES D'ADMINISTRATION
Abstract
(EN)
The present invention relates to methods and formulations directed to the management of Cathepsin G, Cathepsin S, Cathepsin B, Cathepsin L, Butyryl Cholinesterase, Peptidase HIV-I, and NF-kB enzymes comprising the administration of processed Morinda citrifolia based formulations.
(FR)
L'invention concerne des méthodes et des formulations qui permettent de maîtriser les enzymes suivantes : cathepsine G, cathepsine S, cathepsine B, cathepsine L, butyryle Cholinesterase, peptidase HIV-I, et NF-kB. Ces méthodes consistent à administrer des formulations à base de Morinda citrifolia traité.
Latest bibliographic data on file with the International Bureau